Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice

Yiannis Mavrommatis, Karen Ross, Garry Rucklidge, Martin Reid, Gary James Duncan, Margaret Jane Gordon, Frank Thies, Alan Arthur Sneddon, Baukje De Roos

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Long-chain n-3 PUFA from fish oil protect against death from CHID but mechanisms are not well understood. Preliminary results indicate that fish oil may affect the enzyme soluble epoxide hydrolase (sEH) and influence inflammatory pathways in a time-dependent manner. In the present study male apoE knockout (Apoe(-/-)) mice were randomised to three dietary groups receiving a high-fat high-cholesterol diet supplemented with 2% (w/w) high-oleic acid sunflower-seed (HOSF) oil, DHA oil or fish oil. Livers and proximal aortas were collected on day 2 and on weeks 1, 2, 4 and 10 to determine hepatic sEH levels, hepatic fatty acid composition, hepatic proteome and atherosclerotic plaque size in the aortic root. Intervention with fish oil, but not with DHA, resulted in significantly lower levels of hepatic sEH levels with time compared with HOSF oil. DHA and fish oil caused differential regulation of thirty-five hepatic proteins which were mainly involved in lipoprotein metabolism and oxidative stress. All mice developed atherosclerosis without differences in plaque size between the three groups. Thus EPA may be responsible for lowering levels of hepatic sEH and both fish oil and DHA could beneficially affect lipoprotein metabolism and oxidative stress.

Original languageEnglish
Pages (from-to)16-24
Number of pages9
JournalBritish Journal of Nutrition
Volume103
Issue number1
Early online date13 Aug 2009
DOIs
Publication statusPublished - 14 Jan 2010

Keywords

  • epoxyeicosatrienoic acids
  • n-3 Fatty acids
  • proteomics
  • atherosclerosis
  • polyunsaturated fatty-acids
  • coronary heart-disease
  • eicosapentaenoic acid
  • atherosclerotic lesions
  • dietary supplementation
  • myocardial-infarction
  • APOE(-/-) MICE
  • metabolism
  • liver
  • Epoxyeicosatrienoic acids
  • Proteomics
  • Atherosclerosis

Cite this

Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice. / Mavrommatis, Yiannis; Ross, Karen; Rucklidge, Garry ; Reid, Martin ; Duncan, Gary James; Gordon, Margaret Jane; Thies, Frank; Sneddon, Alan Arthur; De Roos, Baukje.

In: British Journal of Nutrition, Vol. 103, No. 1, 14.01.2010, p. 16-24.

Research output: Contribution to journalArticle

@article{866a9a4b590e4a5299547c124e983e14,
title = "Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice",
abstract = "Long-chain n-3 PUFA from fish oil protect against death from CHID but mechanisms are not well understood. Preliminary results indicate that fish oil may affect the enzyme soluble epoxide hydrolase (sEH) and influence inflammatory pathways in a time-dependent manner. In the present study male apoE knockout (Apoe(-/-)) mice were randomised to three dietary groups receiving a high-fat high-cholesterol diet supplemented with 2{\%} (w/w) high-oleic acid sunflower-seed (HOSF) oil, DHA oil or fish oil. Livers and proximal aortas were collected on day 2 and on weeks 1, 2, 4 and 10 to determine hepatic sEH levels, hepatic fatty acid composition, hepatic proteome and atherosclerotic plaque size in the aortic root. Intervention with fish oil, but not with DHA, resulted in significantly lower levels of hepatic sEH levels with time compared with HOSF oil. DHA and fish oil caused differential regulation of thirty-five hepatic proteins which were mainly involved in lipoprotein metabolism and oxidative stress. All mice developed atherosclerosis without differences in plaque size between the three groups. Thus EPA may be responsible for lowering levels of hepatic sEH and both fish oil and DHA could beneficially affect lipoprotein metabolism and oxidative stress.",
keywords = "epoxyeicosatrienoic acids, n-3 Fatty acids, proteomics, atherosclerosis, polyunsaturated fatty-acids, coronary heart-disease, eicosapentaenoic acid, atherosclerotic lesions, dietary supplementation, myocardial-infarction, APOE(-/-) MICE, metabolism, liver, Epoxyeicosatrienoic acids, Proteomics, Atherosclerosis",
author = "Yiannis Mavrommatis and Karen Ross and Garry Rucklidge and Martin Reid and Duncan, {Gary James} and Gordon, {Margaret Jane} and Frank Thies and Sneddon, {Alan Arthur} and {De Roos}, Baukje",
year = "2010",
month = "1",
day = "14",
doi = "10.1017/S0007114509991450",
language = "English",
volume = "103",
pages = "16--24",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge Univ. Press.",
number = "1",

}

TY - JOUR

T1 - Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice

AU - Mavrommatis, Yiannis

AU - Ross, Karen

AU - Rucklidge, Garry

AU - Reid, Martin

AU - Duncan, Gary James

AU - Gordon, Margaret Jane

AU - Thies, Frank

AU - Sneddon, Alan Arthur

AU - De Roos, Baukje

PY - 2010/1/14

Y1 - 2010/1/14

N2 - Long-chain n-3 PUFA from fish oil protect against death from CHID but mechanisms are not well understood. Preliminary results indicate that fish oil may affect the enzyme soluble epoxide hydrolase (sEH) and influence inflammatory pathways in a time-dependent manner. In the present study male apoE knockout (Apoe(-/-)) mice were randomised to three dietary groups receiving a high-fat high-cholesterol diet supplemented with 2% (w/w) high-oleic acid sunflower-seed (HOSF) oil, DHA oil or fish oil. Livers and proximal aortas were collected on day 2 and on weeks 1, 2, 4 and 10 to determine hepatic sEH levels, hepatic fatty acid composition, hepatic proteome and atherosclerotic plaque size in the aortic root. Intervention with fish oil, but not with DHA, resulted in significantly lower levels of hepatic sEH levels with time compared with HOSF oil. DHA and fish oil caused differential regulation of thirty-five hepatic proteins which were mainly involved in lipoprotein metabolism and oxidative stress. All mice developed atherosclerosis without differences in plaque size between the three groups. Thus EPA may be responsible for lowering levels of hepatic sEH and both fish oil and DHA could beneficially affect lipoprotein metabolism and oxidative stress.

AB - Long-chain n-3 PUFA from fish oil protect against death from CHID but mechanisms are not well understood. Preliminary results indicate that fish oil may affect the enzyme soluble epoxide hydrolase (sEH) and influence inflammatory pathways in a time-dependent manner. In the present study male apoE knockout (Apoe(-/-)) mice were randomised to three dietary groups receiving a high-fat high-cholesterol diet supplemented with 2% (w/w) high-oleic acid sunflower-seed (HOSF) oil, DHA oil or fish oil. Livers and proximal aortas were collected on day 2 and on weeks 1, 2, 4 and 10 to determine hepatic sEH levels, hepatic fatty acid composition, hepatic proteome and atherosclerotic plaque size in the aortic root. Intervention with fish oil, but not with DHA, resulted in significantly lower levels of hepatic sEH levels with time compared with HOSF oil. DHA and fish oil caused differential regulation of thirty-five hepatic proteins which were mainly involved in lipoprotein metabolism and oxidative stress. All mice developed atherosclerosis without differences in plaque size between the three groups. Thus EPA may be responsible for lowering levels of hepatic sEH and both fish oil and DHA could beneficially affect lipoprotein metabolism and oxidative stress.

KW - epoxyeicosatrienoic acids

KW - n-3 Fatty acids

KW - proteomics

KW - atherosclerosis

KW - polyunsaturated fatty-acids

KW - coronary heart-disease

KW - eicosapentaenoic acid

KW - atherosclerotic lesions

KW - dietary supplementation

KW - myocardial-infarction

KW - APOE(-/-) MICE

KW - metabolism

KW - liver

KW - Epoxyeicosatrienoic acids

KW - Proteomics

KW - Atherosclerosis

U2 - 10.1017/S0007114509991450

DO - 10.1017/S0007114509991450

M3 - Article

VL - 103

SP - 16

EP - 24

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 1

ER -